Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2023 Apr;41(4):989-990.
doi: 10.55563/clinexprheumatol/032qke. Epub 2023 Mar 20.

New-onset aortitis manifesting as relapsing giant cell arteritis successfully managed with tocilizumab monotherapy. A comment on: Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients. by Calderon-Goerc

Max Guarda  1 , Philip A Araoz  2 , Umar Ghaffar  3 , Kenneth J Warrington  1 , Matthew J Koster  4
Affiliations
Free article
Multicenter Study

New-onset aortitis manifesting as relapsing giant cell arteritis successfully managed with tocilizumab monotherapy. A comment on: Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients. by Calderon-Goerc

Max Guarda et al. Clin Exp Rheumatol. 2023 Apr.
Free article
No abstract available

PubMed Disclaimer

Comment in

Comment on

  • Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients.
    Calderón-Goercke M, Loricera J, Moriano C, Castañeda S, Narváez J, Aldasoro V, Maiz O, Melero R, Villa JI, Vela P, Romero-Yuste S, Callejas JL, de Miguel E, Galíndez-Agirregoikoa E, Sivera F, Fernández-López JC, Galisteo C, Ferraz-Amaro I, Sanchéz-Martín J, Sánchez-Bilbao L, González-Gay MA, Hernández JL, Blanco R; Tocilizumab in Giant Cell Arteritis Spanish Collaborative Group. Calderón-Goercke M, et al. Clin Exp Rheumatol. 2023 Apr;41(4):829-836. doi: 10.55563/clinexprheumatol/oqs8u9. Epub 2022 Nov 2. Clin Exp Rheumatol. 2023. PMID: 36377586

MeSH terms

Substances

LinkOut - more resources